New China Life Insurance (1336)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 39.58 |
|---|---|
| 52-week range | 39.50 – 62.55 |
| Return, 1 month / 3 months | −15.1% / −17.9% |
| Return, 1 year / 3 years | −10.2% / +150.0% |
| Trend | Below its 200-day average |
| RSI (14) | 22 |
| Volatility (1 year) | 39.8% |
| Worst drawdown (1 year) | -36.1% |
| Average daily value traded | 317.52M HKD |
| Dividend yield | 7.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
New China Life Insurance is a life insurance company based in China. It provides life insurance, health insurance and accident insurance products to individual customers and to groups. The company distributes its policies through its own sales agents, through partnerships with banks and through other channels across the Chinese market. Its business centres on protecting policyholders and paying claims, and it also manages investment assets to back its insurance obligations.
New China Life Insurance trades under the code 1336 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
New China Life Insurance (1336) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 39.58 on 20 October 2026.
Its price-based Market X-Ray is 63 out of 100 (a fair price profile), ranking 753 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 10.2% and over the last three months it fell 17.9%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 47 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -19.3% | ||
| From 52-week high | -36.1% | ||
| Momentum | 46 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -17.9% | ||
| 6-month return | -17.1% | ||
| 12-month return, skipping the last month | 5.9% | ||
| Stability (higher is calmer) | 72 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 39.8% | ||
| Worst drawdown, 1 year (smaller is calmer) | -36.1% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 317.52M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.8% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −10.8% |
|---|---|
| 1 month | −15.1% |
| 3 months | −17.9% |
| 6 months | −17.1% |
| 1 year | −10.2% |
| 3 years | +150.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 46.11 / 49.06 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.24 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Jul 2026 | HKD 2.3687 |
| 13 Nov 2025 | HKD 0.7344 |
| 10 Jul 2025 | HKD 2.1795 |
| 14 Nov 2024 | HKD 0.5895 |
| 11 Jul 2024 | HKD 0.9316 |
| 6 Jul 2023 | HKD 1.1779 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.